Tag: deep vein thrombosis
First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates...
Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis...
US study highlights racial and ethnic disparities in the placement of...
A nationwide US study, recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), showed that Black patients had the highest...
Manj Gohel
“As I learned more about venous pathologies, it became abundantly clear that patients with venous disease were a largely neglected population in need of...
Approaching combined disease: Treat superficial, deep or both?
Mona Gupta (Chicago, USA) writes about the importance of acknowledging the “complex relationship” between the deep and superficial venous systems.
The complex relationship between the...
Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis...
Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores...
Large administrative databases enter crosshairs as comparative analysis shows percutaneous mechanical...
The pitfalls of large administrative databases came to the fore during the presentation of a propensity-match scoring analysis demonstrating that percutaneous mechanical thrombectomy (MT)...
One-year CLOUT data demonstrate low rate of PTS following treatment with...
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
Erin Murphy
“Occasionally, taking a step in a different direction can pave the way for substantial strides forward,” Erin Murphy, MD, tells Venous News, recalling her...
The pulmonary arterial tree—it is time we branch out
Nicolas J Mouawad (McLaren Health System, Bay City, USA) urges vascular surgeons to “get out of their comfort zone” and become more involved in...
Mechanical thrombectomy: ClotTriever offers “extended window” for DVT treatment
This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies.
During a recent webinar hosted by Inari Medical, a multidisciplinary group...
ClotTriever “makes fast, safe and efficient thrombectomy possible”
This advertorial is sponsored by Inari Medical
“We need to eliminate symptoms as fast as possible—it is not OK just to make things a little...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
Study finds anatomic positioning and physical activity type can cause device...
A recent multicentre, prospective study has found that stent deformations are greater in the common iliac vein with higher levels of hip flexion, as...
CX 2023 seeks consensus in “rapidly” progressing venous field
The CX 2023 Venous & Lymphatic programme it set to be a “highlight” of this year’s meeting, CX co-chair and executive board member Erin...
AVF 2023: One-year analysis of CLOUT registry reveals “significant and sustained”...
Interim one-year outcomes from the multicentre, prospective, single-arm CLOUT registry investigating use of the ClotTriever thrombectomy system (Inari Medical) in all-comer patients with deep...
Inari Medical announces first patient enrolment in DEFIANCE trial of the...
Inari Medical has announced that the first patient has been enrolled in DEFIANCE, a prospective randomised controlled trial (RCT) comparing the clinical outcomes of...
Thrombectomy for DVT associated with reduced ICU cost when compared with...
A retrospective review, presented as a late-breaking clinical trial at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA), indicates that...
Mechanical thrombectomy for DVT: Randomised data needed to boost growing evidence...
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA)—the latest results...
ClotTriever deemed a “game-changer” in deep vein thrombosis treatment
This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies.
“I am finally very confident I have a device that...
Why ClotTriever is a “gamechanger” for the treatment of deep vein...
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) discuss the current state of deep vein thrombosis (DVT) treatment at the Leipzig Interventional...
Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard...
Inari Medical announces randomised controlled trial evaluating clinical outcomes of the...
Inari Medical has announced planned enrolment of the DEFIANCE randomised controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
Machine-learning software aids non-experts in performing “safe and efficient” remote DVT...
In a prospective, controlled clinical trial of deep vein thrombosis (DVT) triage using artificial intelligence (AI)-guided software simulating compression ultrasonography, lead investigator Efthymios Avgerinos...
Study finds increased risk of serious blood clots up to six...
A study from Sweden published by The BMJ recently finds an increased risk of deep vein thrombosis (DVT) up to three months after COVID-19 infection,...
Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
First New England enrolment into the DEXTERITY clinical trials announced
Vascular Breakthroughs and Vascular Care Connecticut have announced the first New England enrolment into the novel DEXTERITY clinical trials of local anti-inflammatory therapy to...
AVF 2022: Emerging autogenous venous valve formation system sees “continual improvement”
An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full...
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system (Inari Medical) in a real-world deep vein...
Cardiovascular Systems partners with Innova Vascular to develop full line of...
Cardiovascular Systems Inc (CSI) recently announced it has partnered with Innova Vascular (Innova) to develop a full line of novel thrombectomy devices.
According to a...
Systematic review deems ablation of superficial venous reflux safe for patients...
In patients with concurrent deep venous obstruction (DVO), superficial venous reflux (SVR) ablation is suggested to be safe, according to a recent systematic review....
Abre venous stent “remains safe and effective” out to 24 months,...
The Abre venous stent (Medtronic) remains safe and effective for the treatment of iliofemoral venous obstructive disease out to 24 months. This is according...
NIH grant sets Mercator research underway for local anti-inflammatory DVT therapy
Mercator MedSystems has recently announced that the DEXTERITY trials research has begun under a technology transfer grant for approximately $300,000 funded by the National...
Compression stockings after endovenous thermal ablation of varicose veins “bring no...
A systematic review and meta-analysis published online in the European Journal of Vascular and Endovascular Surgery has suggested that, following endovenous thermal ablation of...
Recommendation for repeat imaging after incomplete ultrasound exam increases follow-up rate
The rate of follow-up after an incomplete and negative lower extremity venous duplex ultrasound (I/N LEVDUS) has been shown to increase following a specific...
Mercator announces enrolment of first patient in DEXTERITY-AFP clinical trial treating...
Mercator MedSystems has announced enrolment of the first patient in the DEXTERITY (Dexamethasone therapy examining reduction of inflammation after thrombus removal to yield benefit...
Five-year, single-centre VenaSeal outcomes for symptomatic saphenous incompetence revealed
Morwan Bahi (Wellington Regional Hospital, Wellington, New Zealand) presented five-year results of a retrospective, observational, single-centre study detailing outcomes for all patients with symptomatic...
Registry data show greater clot chronicity on postprocedure inspection than initially...
Nearly half of patients deemed preprocedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
CLOUT registry: Inari Medical announces positive interim results from first 250...
Inari Medical today announced "strongly positive" interim results from the first 250 deep vein thrombosis (DVT) patients enrolled in the CLOUT (ClotTriever outcomes) registry....
Researchers recommend national registries address geographical variation in DVT guideline implementation
A new review concludes that the implementation of clinical guidelines for the management of patients with deep vein thrombosis (DVT) varies among countries, from...
New medical device removes large blood clots in DVT patients
Control Medical Technology recently announced that their US Food and Drug Administration (FDA)-cleared Control 11F mechanical thrombectomy system has been used to remove large...
Systematic review finds high risk of deep vein thrombosis and pulmonary...
In a systematic review of the worldwide published data on venous thromboembolism (VTE) in COVID-19 patients, Cihan Ay, Stephan Nopp, and Florian Moik (Medical...
Intracranial haemorrhage rare in patients treated with catheter-directed thrombolysis for proximal...
In a recent nationwide study of observational data from the USA, intracranial haemorrhage (ICH) was found to be rare among deep vein thrombosis (DVT)...
Study finds death rates from PE have been rising over the...
The American Heart Association (AHA) has announced that after nearly a decade of steady decline, the death rate for people with pulmonary embolism (PE)...
CLEAR-DVT highlights “real paradigm shift” in treatment of DVT patients
Venous News takes a look back at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) where Stephen Black (London, UK) and Mitchell Silver (Columbus, USA) discuss the CLEAR-DVT study.
Silver touches...
COVID-19 will have “massive long-term impact” on treatment of venous disease...
Manj Gohel (Cambridge, UK) is joined by a host of venous experts including Beverley Hunt (London, UK), Stephen Black (London, UK) and Ian Franklin...
At six months, adjunctive mechanical thrombectomy associated with higher patency and...
A recent systematic review and meta-analysis showed that, in patients with iliofemoral deep vein thrombosis (DVT), percutaneous mechanical thrombectomy was associated with a higher...
Compression stockings might not be needed to prevent blood clots after...
Compression stockings might be unnecessary to prevent blood clots in most patients undergoing non-emergency (elective) surgery, finds a clinical trial published by The BMJ...
Review of clot removal system shows positive short-term outcomes for lower...
Use of the ClotTreiver system (Inari Medical) for the treatment of lower extremity deep vein thrombosis (DVT) has demonstrated safety and efficacy, especially in...
Where does the CAVA trial leave early thrombus removal for iliofemoral...
Results from the Dutch CAVA trial were published recently in The Lancet Haematology and, at first glance, this is another trial that failed to...
ATTRACT analysis finds improved quality of life for iliofemoral DVT patients...
An analysis of data from the ATTRACT trial, published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL), reveals that quality of...
FDA approves first generics of Eliquis for prophylaxis of DVT and...
The US Food and Drug Administration (FDA) has announced the approval of two applications for the first generics of Eliquis (apixaban) tablets, to reduce...
VIVA 2019: Open vein hypothesis has “validity” for DVT patients, but...
Suresh Vedantham (St Louis, USA) talks to BLearning Venous after winning the prestigious VEINS award at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las...
Clinical data on the ClotTriever system demonstrates efficacy for DVT treatment
Inari Medical has announced the presentation of early outcomes from the ClotTriever Outcomes Registry (CLOUT) using the ClotTriever Mechanical Thrombectomy System for treatment of...
Most reinterventions following treatment of iliofemoral DVT could be due to...
Analysing the results of a retrospective, single-centre cohort study conducted at Guys and St Thomas’ Hospital, London, UK, Anna Pouncey (Guys and St Thomas’...
Future trials on the management of DVT “have to focus on...
Speaking at the annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2019; 7–11 September, Barcelona, Spain), Stephen Black (Guys and...
New ATTRACT data show catheter-based therapy significantly reduces leg symptoms and...
A new study, recently published online in the journal Circulation, reports on outcomes from a subgroup of 391 patients with acute iliofemoral deep venous...
BTG to begin European distribution of EKOS Control unit 4.0
BTG has announced that the first EKOS Control Unit 4.0 have been shipped from BTG’s facility in Bothell (Washington, USA) to Europe, where full...
Worse outcomes in peripartum compared to non-pregnant women stented for DVT
Peripartum women with deep vein thrombosis (DVT) treated with catheter-directed thrombolysis and venous stenting had significantly increased rates of reintervention and loss of stent patency...
NexGen Medical Systems launches XCOIL large vessel thrombectomy system
NexGen Medical Systems, Inc., a US medical device company, has announced the successful completion of the first human use of their XCOIL large vessel (18mm)...
Ultrasound-enhanced catheter-directed thrombolysis as the standard of care for acute DVT
Ash Verma, Clearwater, USA, writes how last year, he happened upon a routine case that struck him as both totally unremarkable and absolutely extraordinary....